HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 201 filers reported holding HORIZON PHARMA PLC in Q2 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,200,000 | -1.9% | 83,225 | -27.5% | 0.01% | -14.3% |
| Q4 2018 | $2,243,000 | -14.4% | 114,802 | -14.2% | 0.01% | 0.0% |
| Q3 2018 | $2,619,000 | -9.0% | 133,754 | -23.1% | 0.01% | -22.2% |
| Q2 2018 | $2,879,000 | +9.2% | 173,877 | -6.4% | 0.02% | +5.9% |
| Q1 2018 | $2,637,000 | +40.4% | 185,684 | +44.4% | 0.02% | +41.7% |
| Q4 2017 | $1,878,000 | +15.4% | 128,606 | +0.2% | 0.01% | +9.1% |
| Q3 2017 | $1,627,000 | +25.7% | 128,348 | +17.8% | 0.01% | +37.5% |
| Q2 2017 | $1,294,000 | +5.6% | 108,994 | +31.5% | 0.01% | +14.3% |
| Q1 2017 | $1,225,000 | +171.6% | 82,883 | +197.1% | 0.01% | +250.0% |
| Q4 2016 | $451,000 | +132.5% | 27,898 | +161.3% | 0.00% | +100.0% |
| Q3 2016 | $194,000 | +10.2% | 10,677 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $176,000 | – | 10,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scale Management, LLC | 1,710,451 | $37,065,000 | 56.74% |
| Broadfin Capital, LLC | 8,131,310 | $176,205,000 | 10.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,684,801 | $253,210,000 | 10.26% |
| ATERNALIS CAPITAL LLC | 410,000 | $8,885,000 | 5.84% |
| JW Asset Management, LLC | 673,075 | $14,586,000 | 5.44% |
| NEXTHERA CAPITAL LP | 144,000 | $3,120,000 | 4.43% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 739,485 | $16,025,000 | 2.77% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,519,955 | $54,607,000 | 2.66% |
| Ratan Capital Management LP | 500,000 | $10,835,000 | 2.39% |
| TIGER MANAGEMENT L.L.C. | 823,577 | $17,847,000 | 2.30% |